insights_auto
Why is PTX down 7.94%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
AU$0.058
arrow_downward
-7.94%(-0.0050) 1D
ኖቬም 13, 4:10:12 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
AU$0.06
High
AU$0.06
Low
AU$0.06
Mkt. cap
69.66 ሚ
Avg. vol.
490.16 ሺ
Volume
112.89 ሺ
52-wk high
AU$0.12
52-wk low
AU$0.05
EPS
-AU$0.01
Shares outstanding
1.14 ቢ
No. of employees
3
Open
AU$0.06
High
AU$0.06
Low
AU$0.06
Mkt. cap
69.66 ሚ
Avg. vol.
490.16 ሺ
Volume
112.89 ሺ
52-wk high
AU$0.12
52-wk low
AU$0.05
EPS
-AU$0.01
Shares outstanding
1.14 ቢ
No. of employees
3
News stories
From web sources and news partners
Trefis
·
ከ2 ሰዓቶች በፊት
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
qz.com
·
ከ12 ሰዓቶች በፊት
How much of the S&P 500 is Nvidia? Concentration explained
Advisor Perspectives
·
ከ26 ደቂቃዎች በፊት
S&P 500 Snapshot: Stocks Up 2.5% to Log Best Week Since August
Traders Union
·
ከ19 ሰዓቶች በፊት
S&P 500 falls over 1% as selling pressure and cautious trading weigh ahead of inflation data
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
Founded22 ሜይ 1986
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteptxtherapeutics.com